Latest Breaking News On - Jodi sievers - Page 5 : comparemela.com

Coherus BioSciences Announces CFO Transition Plans

Coherus BioSciences Announces CFO Transition Plans
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Jodi sieversMcdavid stilwellJami taylorCoherus biosciencesDenny lanfearExchange commissionVp corporate communicationsCoherus biosciences incChief financial officerPrincipal financial officerPrincipal financialChief executive officerPrivate securities litigation reform actCoheru quarterly report

Coherus Presents Phase 1/2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2023 ESMO Immuno-Oncology Congress

Coherus Presents Phase 1/2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2023 ESMO Immuno-Oncology Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Coherus biosciencesThomas marronJodi sieversJami taylorRosh dias coheruCoherus biosciences incOncology congressVp corporate communicationsExchange commissionPalexpo exhibition centre in genevaTisch cancer centerPalexpo exhibition centreEarly phase trials unitTisch cancerRosh dias coheru chief medicalOrphan drug

Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights

– Net revenue rose 27% from prior quarter to $74.6 million –– CIMERLI® net sales increased 50% to $40 million compared to prior quarter –– LOQTORZI™ now approved with launch planned for.

Junshi biosciencesJami taylorJodi sieversCoherus biosciencesDenny lanfearMeeting of societyAmgen incDrug administrationSurface oncology incInternational conference on molecularAbbvie incExchange commission onCorporate communicationsCoherus biosciences incExchange commissionGenentech inc

Coherus Presents Data from Next-generation Immuno-oncology Programs at 38th Annual Meeting of Society for Immunotherapy of Cancer (SITC)

– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in vitro, supporting ongoing clinical development of first-in-class anti-IL-27 antibody.

San diegoUnited statesSan diego convention centerCoherus biosciencesJami taylorJodi sieversTheresa lavalleeExchange commissionVp corporate communicationsCoherus biosciences incDrug administrationAnnual meetingDaylight timeExhibit hallsSan diego conventionSurface oncology

Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023

Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Jodi sieversCoherus biosciences incCorporate communicationsReport third quarterQuarterly reportContact information